Flagship explainer

What drives Haemonetics Corporation’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity12%Tax burden76%net income ÷ pretax incomeInterest burden82%pretax ÷ operating incomeOperating margin12%operating income ÷ revenueAsset turnover0.55×revenue ÷ average assetsEquity multiplier3.00×average assets ÷ average equityAs of 2026-03-28 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
$97.3MFY2026
Income before tax$128MFY2026
Operating income$157MFY2026
$1.3BFY2026
Ending assets$2.4BFY2026
Beginning assets$2.5BFY2025
$796MFY2026
$821MFY2025
Source: · event Mar 28, 2026 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full Haemonetics Corporation analysis at Buy Like Buffett